Posts by cstephenson@legacymedsearch.com
Florida Hospital First in State to Adopt BodyTom Elite, Samsung’s Updated CT Scanner
DANVERS, MA, June 7, 2018 – NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd., a leader in medical imaging technology, announced today that Florida Hospital in Orlando, Fl., added the BodyTom® Elite, the newly upgraded, portable, 32-slice computed tomography scanner, to their brachytherapy suite. The BodyTom Elite improves the patient experience, patient safety and workflow efficiency by…
Read MoreBrain Stimulation May Reduce Desire to Commit Sexual Assault
Stimulating the prefrontal cortex, the part of the brain responsible for controlling complex ideas and behaviors, can reduce a person’s intention to commit a violent act by more than 50 percent, according to research published in the Journal of Neuroscience from the University of Pennsylvania and Nanyang Technological University. What’s more, using such a minimally invasive technique, called transcranial direct-current…
Read MoreMassachusetts Biotech Sees Record Year for IPOs
It’s been a pretty good year for mergers and acquisitions in the biopharma industry, with Takeda Pharmaceutical buying Shire for $62.2 billion, and the year starting with Sanofi buying Bioverativfor $11.6 billion and then Ablynx for $4.8 billion. Celgene acquired Juno Therapeutics for $9 billion, shortly after buying Impact Biomedicines for $1.1 billion. But the landscape for initial public offerings (IPOs) has been excellent as well, particularly in Massachusetts, which has recorded 13 IPOs…
Read MoreMiMedx CEO and President Out Amid Corporate Turmoil
MiMedx, the Marietta biopharma company rocked by allegations of inflated earnings and improper sales practices, said Monday the company’s longtime chairman and CEO has resigned. Parker H. “Pete” Petit, a fixture in metro Atlanta’s business community, resigned both as CEO and chairman, though he will remain a member of the MiMedx board, the company said in…
Read MoreBIOLIFE4D Successfully 3D Bioprints Human Heart Tissue
BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its ability to 3D bioprint human cardiac tissue – specifically, a human cardiac patch. The scientific milestone was accomplished within days of the May opening of the Company’s new research facility at JLABS in…
Read More“Smart Stent” Monitors Blood Flow, Detects Narrowing of Arteries
Vascular stents are some of the most commonly implanted medical devices, keeping millions of arteries open to uninterrupted blood flow. Though they tend to work well at first, too many end up being re-stenosed by new deposits of plaque and scar tissue often forms in the vicinity, blocking blood flow through the stent. Typically, renewed…
Read MoreGE to Spin Off Healthcare Division
After a year of soul searching and strategic review, GE announced its move today to spin off GE Healthcare into a standalone company over the next 12 to 18 months. The goal, the company said, is a leaner corporate structure with substantial reductions in debt. Healthcare is one of eight businesses GE operates that also…
Read MoreFDA Approves First Marijuana-derived Drug for Severe Forms of Epilepsy
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana.…
Read MoreHeartSciences Named “Start-Up to Watch”
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences is delighted to have been highlighted as “Start-Up to Watch” in the June 8, 2018 issue of the MedTech Strategist. The article titled “HEARTSCIENCES: ARTIFICIAL INTELLIGENCE IMPROVES FRONTLINE RISK STRATIFICATION FOR HEART DISEASES” discusses HeartSciences’ role in addressing the current challenges and significant unmet need to identify heart disease at an early stage and reduce the…
Read MoreWhite House Proposes 30% Cut to FDA Headcount
The Trump administration this week submitted a proposal that would cut the budget and staff at the FDA, as well as reorganizing the agency to remove food regulation from its purview, according to a new Endpoints News report. The proposal would cut $1.3 billion in resources from the agency and 5,000 members of its staff and leave…
Read More